Erudio Healtherudio.com
Clinical trial · no report yet · Phase 3
NCT02750826
Breast Cancer WEight Loss Study (BWEL Study)
- NCT02750826 ↗
- Active, not recruiting
- Alliance for Clinical Trials in Oncology
- Deep
We haven't built an HCP commentary report on NCT02750826 (Breast Ductal Carcinoma In Situ) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NCT02750826 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 18 | |
| YouTube | 10 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
- Phase
- Phase 3
- Status
- Active, not recruiting
- Conditions
- Breast Ductal Carcinoma In Situ; Invasive Breast Carcinoma; Stage II Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Synchronous Bilateral Breast Carcinoma
- Interventions
- Health Education Program; Weight Loss Intervention
- Arms
- Arm 1: Health Education Program · Other
- Arm 2: Health Education Program + Weight Loss Intervention · Other
- Enrollment
- 3,177
- Primary outcomes
- Invasive disease-free survival
- Sponsor
- Alliance for Clinical Trials in Oncology with National Cancer Institute (NCI), Division of Cancer Control, NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP), Canadian Cancer Trials Group
- Start
- Sep 16, 2016
- Primary completion
- May 30, 2030 (estimated)
- Results posted
- No
- Registry record
- NCT02750826 · updated Sep 2, 2026
Publications
linked from the registry- Liu Y, Xu S, Yang H, Wang Y. Multidimensional risk impact of obesity on breast cancer incidence, treatment, and prognosis. Int J Obes (Lond). 2026 Jun;50(6):1190-1198. doi: 10.1038/s41366-025-02008-9. Epub 2026 Jan 12. PubMed 41526462
- Ligibel JA, Ballman KV, McCall L, Goodwin PJ, Alfano CM, Bernstein V, Crane TE, Delahanty LM, Frank E, Hahn O, Hershman DL, Hopkins JO, Irwin M, Mayer EL, Minasian L, Nebeling L, Neuhouser ML, Paskett ED, Spears PA, Stearns V, Thomson CA, Weiss A, White J, Wadden TA, Winer EP, Hudis C, Partridge AH, Carey LA. Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial. JAMA Oncol. 2025 Oct 1;11(10):1194-1203. doi: 10.1001/jamaoncol.2025.2738. PubMed 40839373
- Shaikh H, Bradhurst P, Ma LX, Tan SYC, Egger SJ, Vardy JL. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD012110. doi: 10.1002/14651858.CD012110.pub2. PubMed 33305350